The Sol Goldman Pancreatic Cancer Research Center


Beginning 2005, income from the Sol Goldman Pancreatic Cancer Research Center endowment, generously donated by the Goldman family, has funded 115 grant proposals, benefiting 51 principal investigators from 16 departments exploring novel avenues of research.

Todd Armstrong, Ph.D.
Senior Research Scientist in Oncology
Developing Iron Oxide Nanoparticles as a Combination Vaccine for Pancreatic Cancer
James Eshleman, M.D., Ph.D.
Ralph H. Hruban Professor in Pancreatic Cancer Research
Are CRISPR-Cas9 targets in PDAC retained in metastases?
Chuan-Hsiang (Bear) Huang, M.D., Ph.D.
Assistant Professor of Pathology
Targeting the PI3-FAK axis in pancreatic cancer
Miho Iijma, M.S., Ph.D.
Professor of Cell Biology
Targeting the KRAS/RHOA-mTORC2-AKT (KAROMA) Mechanism as a Novel Treatment of PDAC
Janielle Maynard, Ph.D.
Postdoctoral Research Fellow in Pathology
Identification of P2 purinergic receptors in pancreatic ductal adenocarcinoma with clinical significance and potential for therapeutic targeting
Nicholas Roberts, Vet.M.B., Ph.D.
Assistant Professor of Pathology and Oncology
High-throughput analysis of CDKN2A variation - 2nd year renewal
Luciane Tsukamoto Kagohara, Ph.D.
Instructor in Oncology
Spatial transcriptomics analysis of pancreatic intraepithelial neoplasia (PanIN): determining the role of the tumor microenvironment (TME) in the progression to invasive carcinoma
Laura Wood, M.D., Ph.D.
Associate Professor in Pathology and Oncology
In Vitro Modeling of the Molecular Drivers of Vascular Invasion in Pancreatic Cancer
Jingyan Xu, M.S., Ph.D.
Assistant Professor in Radiology
Data-adaptive image reconstruction for improved CT imaging of pancreatic cysts